125
Views
64
CrossRef citations to date
0
Altmetric
Original Research

Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles

, , , &
Pages 625-640 | Published online: 11 Feb 2016

References

  • JohansonGModeling of dispositionCharleneAMcQueenAComprehensive Toxicology2OxfordOxford Academic Press2014
  • KrishnanKAndersenMEQuantitative Modeling in Toxicology1st edNew JerseyJohn Wiley & Sons Ltd2010
  • MorkAKJohansonGChemical-specific adjustment factors for intraspecies variability of acetone toxicokinetics using a probabilistic approachToxicol Sci2010116133634820400482
  • AndersenMEClewellHJ3rdGargasMLSmithFAReitzRHPhysiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicol Appl Pharmacol19878721852053824380
  • VernerMAMcDougallRJohansonGUsing population physiologically based pharmacokinetic modeling to determine optimal sampling times and to interpret biological exposure markers: the example of occupational exposure to styreneToxicol Lett2012213229930422677344
  • LiMAl-JamalKTKostarelosKReinekeJPhysiologically based pharmacokinetic modeling of nanoparticlesACS Nano20104116303631720945925
  • OwensDE3rdPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
  • SabaTMPhysiology and physiopathology of the reticuloendothelial systemArch Intern Med19701266103110524921754
  • SarinHPhysiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityJ Angiogenes Res201021420701757
  • LankveldDPOomenAGKrystekPThe kinetics of the tissue distribution of silver nanoparticles of different sizesBiomaterials201031328350836120684985
  • BaloghLNigavekarSSNairBMSignificant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor modelsNanomedicine20073428129617962085
  • HuangXLiLLiuTThe shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivoACS Nano2011575390539921634407
  • HirnSSemmler-BehnkeMSchlehCParticle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEur J Pharm Biopharm201177340741621195759
  • NiidomeTYamagataMOkamotoYPEG-modified gold nano-rods with a stealth character for in vivo applicationsJ Control Release2006114334334716876898
  • KeeneAMPetersDRouseRStewartSRosenETTynerKMTissue and cellular distribution of gold nanoparticles varies based on aggregation/ agglomeration statusNanomedicine(Lond)20127219920922339133
  • LinZMonteiro-RiviereNARiviereJEPharmacokinetics of metallic nanoparticlesWiley Interdiscip Rev Nanomed Nanobiotechnol20157218921725316649
  • FallonMSVarshneyMDennisDMChauhanAA physiologically-based pharmacokinetic model of drug detoxification by nanoparticlesJ Pharmacokinet Pharmacodyn200431538140015669773
  • LinPChenJWChangLWComputational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in miceEnviron Sci Technol200842166264627018767697
  • LeeHALeavensTLMasonSEMonteiro-RiviereNARiviereJEComparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic modelNano Lett20099279479919128005
  • OpitzAWWickstromEThakurMLWagnerNJPhysiologically based pharmacokinetics of molecular imaging nanoparticles for mRNA detection determined in tumor-bearing miceOligonucleotides201020311712520406142
  • MagerDEModyVXuCPhysiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo dispositionPharm Res20122992534254222688900
  • LiMPanagiZAvgoustakisKReinekeJPhysiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG contentInt J Nanomedicine201271345135622419876
  • BachlerGvon GoetzNHungerbuhlerKA physiologically based pharmacokinetic model for ionic silver and silver nanoparticlesInt J Nanomedicine201383365338224039420
  • LiDJohansonGEmondCCarlanderUPhilbertMJollietOPhysiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in ratsNanotoxicology20148S112813724392664
  • LinZMonteiro-RiviereNARiviereJEA physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult miceNanotoxicology201511125961857
  • ElgrabliDBeaudouinRJbilouNBiodistribution and clearance of TiO2 nanoparticles in rats after intravenous injectionPLoS One2015104e012449025909957
  • GilkeyMJKrishnanVScheetzLJiaXRajasekaranAKDhurjatiPSPhysiologically based pharmacokinetic modeling of fluorescently labeled block copolymer nanoparticles for controlled drug delivery in leukemia therapyCPT Pharmacometrics Syst Pharmacol201543e0001326225236
  • BachlerGvon GoetzNHungerbuhlerKUsing physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticlesNanotoxicology20159337338025058655
  • WengerYSchneiderRJ2ndReddyGRKopelmanRJollietOPhilbertMATissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the ratToxicol Appl Pharmacol2011251318119021134391
  • WangLLiYFZhouLCharacterization of gold nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical formsAnal Bioanal Chem201039631105111420016883
  • ShinoharaNDannoNIchinoseTTissue distribution and clearance of intravenously administered titanium dioxide (TiO2) nanoparticlesNanotoxicology20148213214123272772
  • BrownRPDelpMDLindstedtSLRhombergLRBelilesRPPhysiological parameter values for physiologically based pharmacokinetic modelsToxicol Ind Health19971344074849249929
  • ErikssonERoyoFLybergKCarlssonHEHauJEffect of metabolic cage housing on immunoglobulin A and corticosterone excretion in faeces and urine of young male ratsExp Physiol200489442743315131075
  • YokelRGrulkeEMacPhailRMetal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organismWiley Interdiscip Rev. Nanomed Nanobio-technol201354346373
  • FrigellJGarciaIGomez-VallejoVLlopJPenadesS(68)Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugationJ Am Chem Soc2014136144945724320878
  • SonavaneGTomodaKMakinoKBiodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle sizeColloids Surf B Biointerfaces200866227428018722754
  • KolharPAnselmoACGuptaVUsing shape effects to target antibody-coated nanoparticles to lung and brain endotheliumProc Natl Acad Sci U S A201311026107531075823754411
  • GeraetsLOomenAGKrystekPTissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in ratsPart Fibre Toxicol2014113024993397
  • AlpiniGPhillipsJOVromanBLaRussoNFRecent advances in the isolation of liver cellsHepatology19942024945148045510
  • MirfazaelianAKimKBLeeSKimHJBrucknerJVFisherJWOrgan growth functions in maturing male Sprague-Dawley ratsJ Toxicol Environ Health A200770542943817454567
  • KrishnanKHaddadSPelekisMA simple index for representing the discrepancy between simulations of physiological pharmacokinetic models and experimental dataToxicol Ind Health19951144134228748422
  • KhlebtsovNDykmanLBiodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studiesChem Soc Rev20114031647167121082078
  • HalpernBNBenacerrafBBiozziGQuantitative study of the granulopectic activity of the reticulo-endothelial system. I. The effect of the ingredients present in India ink and of substances affecting blood clotting in vivo on the fate of carbon particles administered intravenously in rats, mice and rabbitsBr J Exp Pathol195334442644013093914
  • PanagiZBeletsiAEvangelatosGLivaniouEIthakissiosDSAvgoustakisKEffect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticlesInt J Pharmaceut20012211–2143152
  • GordonSTaylorPRMonocyte and macrophage heterogeneityNat Rev Immunol200551295396416322748
  • SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Control Release2010145318219520226220
  • ChithraniBDGhazaniAAChanWCDetermining the size and shape dependence of gold nanoparticle uptake into mammalian cellsNano lett20066466266816608261
  • JiangWKimBYRutkaJTChanWCNanoparticle-mediated cellular response is size-dependentNat Nanotechnol20083314515018654486
  • LucianiNGazeauFWilhelmCReactivity of the monocyte/ macrophage system to superparamagnetic anionic nanoparticlesJ Mater Chem2009193563736380
  • LesniakAFenaroliFMonopoliMPAbergCDawsonKASalvatiAEffects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cellsACS Nano2012675845585722721453
  • AlkilanyAMMurphyCJToxicity and cellular uptake of gold nano-particles: what we have learned so far?J Nanopart Res20101272313233321170131
  • FerrariRLupiMColomboCMorbidelliMD’IncalciMMoscatelliDInvestigation of size, surface charge, PEGylation degree and concentration on the cellular uptake of polymer nanoparticlesColloids Surf B Biointerfaces201412363964725456985
  • JinHHellerDASharmaRStranoMSSize-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticlesACS Nano20093114915819206261
  • GrefRLuckMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
  • NelAEMadlerLVelegolDUnderstanding biophysicochemical interactions at the nano-bio interfaceNat Mater20098754355719525947
  • LundqvistMStiglerJCedervallTThe evolution of the protein corona around nanoparticles: a test studyACS Nano2011597503750921861491
  • SahnehFDScoglioCMMonteiro-RiviereNARiviereJEPredicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modelingNanomedicine (Lond)2015101253325032980
  • PraetoriusATufenkjiNGossKUScheringerMvon der KammerFElimelechMThe road to nowhere: equilibrium partition coefficients for nanoparticlesEnviron-Sci Nano201414317323
  • JohansonGModeling of dispositionReference Module in Biomedical SciencesElsevier2015
  • LinICLiangMLiuTYMonteiroMJTothICellular transport pathways of polymer coated gold nanoparticlesNanomedicine20128181122024197
  • PraetnerMRehbergMBihariPThe contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivoBiomaterials201031266692670020619783
  • GrattonSERoppPAPohlhausPDThe effect of particle design on cellular internalization pathwaysProc Natl Acad Sci U S A200810533116131161818697944
  • BernareggiARowlandMPhysiologic modeling of cyclosporin kinetics in rat and manJ Pharmacokinet Biopharm199119121502023108
  • TravlosGSNormal structure, function, and histology of the bone marrowToxicol Pathol200634554856517067943